赛诺菲宣布16亿美元收购!

生物制品圈
26 Jul

近期,制药企业在呼吸道疫苗市场动作频频。赛诺菲公司日前宣布,将以高达 16 亿美元的价格收购英国生物技术公司 Vicebio Ltd. 。根据协议,赛诺菲将预先支付 11.5 亿美元,后续若某些关键节点达成协议,还将支付高达 4.5 亿美元的额外款项。通过此次收购,赛诺菲不仅获得了 Vicebio 处于探索性临床试验阶段、针对呼吸道合胞病毒(RSV)和人类偏肺病毒(hMPV)的单一疫苗,还有望借助...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10